Avidity Biosciences remains a Strong Buy for me, driven by Del-zota's promising data in targeting Duchenne Muscular Dystrophy ...

Avidity Biosciences, Inc. ( NASDAQ: RNA) Discusses on Redefining the Treatment of Duchenne Muscular Dystrophy Conference Call September 10, 2025 8:00 AM EDT ...

OMUFA MAY HITCH A RIDE — The House GOP stopgap funding bill includes a reauthorization of the FDA’s Over-the-Counter ...

A global design and engineering firm that’s worked on Olympics from Sydney in 2000 to Paris in 2024 will lead the ...

The Gabriella Miller Kids First Pediatric Research Program (Kids First) has released its 36th study and introduced significant new data updates to two existing studies, further advancing efforts to ...

After decades without much movement, a handful of new treatments for this rare autoimmune disease are now approved, and ...

At 72, Karki becomes Nepal’s first Madam Prime Minister, who was also the first female chief justice in 2016. She studied at ...

Durable reductions in seizures and continuing improvements in cognition and behavior through 3 years in patients who continued to receive zorevunersen in the open-label extension studies - ...

Stoke Therapeutics , Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine, and Biogen Inc. (Nasdaq: BIIB), today ...

These data are groundbreaking, demonstrating that olezarsen is the first therapy for sHTG to significantly reduce acute pancreatitis events,” said Sam Tsimikas, M.D., senior vice president, global ...

Adobe Illustrator is a vector design software used for things like image editing, graphic design, creating logos, and more. While it can be used for both hobbyists and professionals, the price tag is ...

Chantar, principal investigator at CIC bioGUNE and CIBERehd, has identified a new therapeutic target for cholangiocarcinoma ...